SCHEMBL19797413

SCHEMBL19797413

CC1(C)c2ccccc2N(c2cc(N3c4ccccc4C(C)(C)c4ccccc43)cc(P(=O)(c3ccccc3)c3cccnc3)c2)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KCNA5 P22460 6/20 0.35
▸ KCNN4 O15554 4/20 0.35
▸ ITGB2 P05107 1/20 0.33
▸ ICAM1 P05362 1/20 0.33
▸ ITGAL P20701 1/20 0.33
▸ HDAC1 Q13547 4/20 0.33
▸ HDAC6 Q9UBN7 4/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797354 0.90 LMNA (0.40) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797411 0.90 ITGB2 (0.39) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797359 0.89 LMNA (0.40) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797392 0.83 EGLN1 (0.41) CYP1A2NPY5REGLN1
SCHEMBL19797381 0.83 LMNA (0.36) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797414 0.82 ITGB2 (0.33) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797389 0.81 EGLN1 (0.39) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797380 0.81 LMNA (0.32) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797358 0.81 LMNA (0.32) LMNAGAAMAPTHTTKMT2A
SCHEMBL19797361 0.81 CYP19A1 (0.37) KCNA5HDAC1HDAC3CYP1A2EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 LMNA 2798/4885GAA 1995/4885MAPT 1528/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 LMNA 3701/4885GAA 3728/4885MAPT 2138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback